Repurposing Colchicine to Combat Residual Cardiovascular Risk: The LoDoCo2 Trial
Simon Kraler, Florian A. Wenzl, Thomas F. Lüscher
Abstract
None related to this manuscript and field.
Topics & Concepts
RepurposingColchicineResidual riskMedicineHydroxymethylglutaryl-CoA Reductase InhibitorsTraditional medicineInternal medicinePharmacologyStatinBiologyEcologyInflammasome and immune disordersinterferon and immune responsesCardiovascular Disease and Adiposity